目的:探讨核蛋白样转录因子核受体亚家族2组E成员1(nuclear receptor subfamily 2 group E member 1,NR2E1)对儿童神经母细胞瘤细胞株IMR-32生长、分裂、增殖的影响。方法:应用LipofectamineTM2000将构建的针对核蛋白样转录因子NR2E1的s...目的:探讨核蛋白样转录因子核受体亚家族2组E成员1(nuclear receptor subfamily 2 group E member 1,NR2E1)对儿童神经母细胞瘤细胞株IMR-32生长、分裂、增殖的影响。方法:应用LipofectamineTM2000将构建的针对核蛋白样转录因子NR2E1的shiRNA质粒载体转染神经母细胞瘤细胞株IMR32,并通过细胞计数法观察细胞生长抑制效应,采用细胞免疫荧光染色检测神经母细胞瘤细胞株IMR32细胞分裂蛋白的表达。结果:核蛋白样转录因子NR2E1的shiRNA质粒转染神经母细胞瘤细胞株IMR32 48 h后,该细胞株生长缓慢;相关细胞核分裂蛋白表达受到明显的抑制。结论:核蛋白样转录因子NR2E1的shiRNA干扰质粒转染神经母细胞瘤细胞株IMR32后,抑制了神经母细胞瘤细胞IMR32的分裂和增殖。展开更多
X-linked congenital adrenal hypoplasia is characterised by the acute onset of primary adrenal insufficiency in infancy or early childhood and hypogonadotropic hypogonadism(HH)at puberty,arising from mutations of the n...X-linked congenital adrenal hypoplasia is characterised by the acute onset of primary adrenal insufficiency in infancy or early childhood and hypogonadotropic hypogonadism(HH)at puberty,arising from mutations of the nuclear receptor subfamily 0 group B member 1(NR0B1)gene.This study investigated an extended family with two affected males(patient A:23 years and patient B:2 months old)and three carrier females.Sequencing analysis of the NR0B1 gene coding region from the family revealed a novel hemizygous deletion[c.604delT;p.(C202Afs*62)]in the two male patients.Furthermore,the patients'respective mothers and their common grandmother had this heterozygous mutation,but it was not present in the Human Gene Mutation Database.The two male patients showed inconsistent clinical features at onset,particularly in early childhood;however,it is possible that the younger patient will eventually show a delay of puberty,feminisation,and nonspermatogenesis in adulthood,similar to that in the older patient.Identification of a novel NR0BI mutation in this family is important for the diagnosis and genetic counselling of children with primary adrenal insufficiency and HH,and will be helpful for predicting long-term clinical symptoms.展开更多
目的:探究核受体亚家族4A组成员1(nuclear receptor subfamily 4 group A member 1,Nr4a1)Nr4a1激动剂胞孢子酮B(cytosporone B,Csn-B)对小鼠噪声暴露后听力损失的治疗作用。方法:采用双氧水刺激HEI-OC1毛细胞系的方法构建氧化应激细胞...目的:探究核受体亚家族4A组成员1(nuclear receptor subfamily 4 group A member 1,Nr4a1)Nr4a1激动剂胞孢子酮B(cytosporone B,Csn-B)对小鼠噪声暴露后听力损失的治疗作用。方法:采用双氧水刺激HEI-OC1毛细胞系的方法构建氧化应激细胞模型;通过实时荧光定量PCR(quantitative real-time PCR,q PCR)检测细胞中Nr4a1的mRNA表达水平;分别通过细胞计数试剂盒(cell counting kit-8,CCK8)及流式细胞术的方法检测细胞活力和细胞凋亡水平以评估Csn-B预处理后经双氧水刺激的细胞状态。构建小鼠噪声性听力损失模型,运用qPCR和免疫荧光技术检测噪声暴露后Nr4a1在小鼠耳蜗中的表达;通过检测听性脑干反应(auditory brainstem response,ABR)评估噪声暴露后以及Csn-B连续治疗13 d后小鼠听力情况。结果:双氧水刺激后HEI-OC1毛细胞中Nr4a1表达上升,细胞活力显著下降,凋亡水平显著升高;Csn-B预处理HEI-OC1毛细胞经双氧水刺激,细胞活力显著高于对照组而凋亡水平则显著低于对照组。在体研究结果显示,噪声暴露后小鼠听力显著降低,Nr4a1在小鼠耳蜗中的表达水平显著升高。噪声暴露后经Csn-B治疗小鼠听力得到改善,主要表现为Click-ABR以及Tone Burst-ABR(4000、8000Hz处)阈值下降。结论:Nr4a1激动剂Csn-B增强内耳毛细胞对氧化应激损伤的抵御能力,部分改善噪声暴露后的小鼠听力。展开更多
目的探讨核受体亚家族2c成员2(nuclear receptor subfamily 2 group C member 2,NR2C2)在泌乳素瘤的表达水平及其与临床特征的关系。方法采用免疫组化染色和蛋白印迹实验检测46例泌乳素瘤患者的肿瘤组织NR2C2表达水平。用RNA干扰技术敲...目的探讨核受体亚家族2c成员2(nuclear receptor subfamily 2 group C member 2,NR2C2)在泌乳素瘤的表达水平及其与临床特征的关系。方法采用免疫组化染色和蛋白印迹实验检测46例泌乳素瘤患者的肿瘤组织NR2C2表达水平。用RNA干扰技术敲低MMQ细胞NR2C2表达水平,行细胞增殖实验检测细胞活力,流式细胞仪检测细胞凋亡率。结果按照Knosp分级将患者分为侵袭组和非侵袭组。侵袭组NR2C2表达的免疫组化评分为148.2±42.7,非侵袭组为45.2±28.72;NR2C2表达水平与肿瘤大小成正相关(r=0.327,P=0.039);疏松颗粒型患者的表达水平更高(P=0.003)。蛋白印迹实验检测NR2C2蛋白水平,筛选出Sh-B(23.4%)和Sh-C(34%)片段;干扰24h、48h和72h后,与对照组相比Sh-B组的细胞活力分别下降24.8%、39.2%和48.3%,Sh-C组分别下降19.1%、26.4%和32.5%(均P<0.05)。干扰24h后,Sh-B组AnnexinV阳性细胞为(10.3±3.1)%,PI阳性细胞为(7.3±2.1)%;Sh-C组分别为(8.5±2.3)%和(5.6±1.8)%;均明显高于对照组(均P<0.05)。结论 NR2C2能促进肿瘤生长,与催乳素腺瘤的发生发展密切相关。展开更多
核受体在细胞稳态的维持以及疾病的发生发展等方面发挥着重要的作用。为了探究核受体亚家族6A组成员1(nuclear receptor subfamily 6 group A member 1,NR6A1)在肝癌中的作用及机制,首先,分析了癌症基因组图谱(The Cancer Genome Atlas,...核受体在细胞稳态的维持以及疾病的发生发展等方面发挥着重要的作用。为了探究核受体亚家族6A组成员1(nuclear receptor subfamily 6 group A member 1,NR6A1)在肝癌中的作用及机制,首先,分析了癌症基因组图谱(The Cancer Genome Atlas,TCGA)等数据库信息,发现NR6A1在肝癌中异常高表达且与患者预后不良有关;然后,通过CCK-8(Cell Counting Kit-8)、5-乙炔基-2′-脱氧尿苷(5-ethynyl-2′-deoxyuridine,EdU)、划痕实验发现,干扰NR6A1使肝癌细胞的增殖明显受到抑制但不影响细胞的迁移;其次,通过免疫共沉淀、免疫荧光、RNA干扰和过表达等实验,鉴定出N-myc下游调控基因1(N-myc downstream-regulated gene 1,NDRG1)是NR6A1在肝癌中的互作蛋白质,二者在肝癌中的表达呈正相关,且NR6A1正调控NDRG1的表达;最后,利用功能拯救实验证实,干扰NDRG1可以抑制NR6A1过表达造成的肝癌细胞增殖增强的现象。综上可知,NR6A1通过与NDRG1相互结合且上调NDRG1的表达来发挥促癌作用。展开更多
目的 探讨乳腺癌患者血清核受体亚家族C组成员2(nuclear receptor subfamily 3, group C, member 2,NR3C2),DNA甲基化转移酶-3A[DNA(cytosine-5)-methyltransferase 3A,DNMT3A]水平及其临床诊断价值。方法收集复旦大学附属华东医院2017...目的 探讨乳腺癌患者血清核受体亚家族C组成员2(nuclear receptor subfamily 3, group C, member 2,NR3C2),DNA甲基化转移酶-3A[DNA(cytosine-5)-methyltransferase 3A,DNMT3A]水平及其临床诊断价值。方法收集复旦大学附属华东医院2017年5月~2020年12月期间住院的94例乳腺癌患者为乳腺癌组,另选取同期健康体检者86例作为对照组。酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测两组血清NR3C2和DNMT3A水平,Pearson法分析乳腺癌患者血清NR3C2和DNMT3A表达水平相关性,多因素Logistic回归分析乳腺癌发生的影响因素,受试者工作特征(receiver operating characteristic,ROC)曲线评估NR3C2和DNMT3A对乳腺癌的诊断价值。结果 乳腺癌组患者血清NR3C2水平为317.84±33.47 ng/L,低于对照组(374.25±47.72ng/L),DNMT3A的表达水平为451.63±75.47μg/L,高于对照组(349.85±63.72μg/L),差异有统计学意义(t=9.243,9.729,均P<0.05)。Pearson分析结果显示,乳腺癌患者血清NR3C2与DNMT3A表达水平存在明显负相关(r=-0.501,P=0.000)。Logistic回归分析结果显示,NR3C2高水平为乳腺癌发生的保护因素(OR=0.563,95%CI:0.372~0.851,P=0.006),DNMT3A高水平是乳腺癌发生的危险因素(OR=1.834,95%CI:1.249~2.693,P=0.002)。ROC曲线结果发现,血清NR3C2与DNMT3A诊断乳腺癌的曲线下面积(area under the curve,AUC)分别为0.853(0.791~0.915),0.930(0.896~0.965),当两者联合时其AUC为0.969(0.949~0.990),高于两者单独检测(Z=3.460,1.894,P=0.000,0.034)。结论 乳腺癌患者血清NR3C2表达水平降低,DNMT3A表达水平升高,两者联合检测能够提高乳腺癌的诊断价值。展开更多
Background and objective:Acute liver failure(ALF)is a type of disease with high mortality and rapid progression with no specific treatment methods currently available.Glucocorticoids exert beneficial clinical effects ...Background and objective:Acute liver failure(ALF)is a type of disease with high mortality and rapid progression with no specific treatment methods currently available.Glucocorticoids exert beneficial clinical effects on therapy for ALF.However,the mechanism of this effect remains unclear and when to use glucocorticoids in patients with ALF is difficult to determine.The purpose of this study was to investigate the specific immunological mechanism of dexamethasone(Dex)on treatment of ALF induced by lipopolysaccharide(LPS)/D-galactosamine(D-Ga IN)in mice.Methods:Male C57 BL/6 mice were given LPS and D-Ga IN by intraperitoneal injection to establish an animal model of ALF.Dex was administrated to these mice and its therapeutic effect was observed.Hematoxylin and eosin(H&E)staining was used to determine liver pathology.Multicolor flow cytometry,cytometric bead array(CBA)method,and next-generation sequencing were performed to detect changes of messenger RNA(m RNA)in immune cells,cytokines,and Kupffer cells,respectively.Results:A mouse model of ALF can be constructed successfully using LPS/D-Ga IN,which causes a cytokine storm in early disease progression.Innate immune cells change markedly with progression of liver failure.Earlier use of Dex,at 0 h rather than 1 h,could significantly improve the progression of ALF induced by LPS/D-Ga IN in mice.Numbers of innate immune cells,especially Kupffer cells and neutrophils,increased significantly in the Dex-treated group.In vivo experiments indicated that the therapeutic effect of Dex is exerted mainly via the glucocorticoid receptor(Gr).Sequencing of Kupffer cells revealed that Dex could increase m RNA transcription level of nuclear receptor subfamily 4 group A member 1(Nr4 a1),and that this effect disappeared after Gr inhibition.Conclusions:In LPS/D-Ga IN-induced ALF mice,early administration of Dex improved ALF by increasing the numbers of innate immune cells,especially Kupffer cells and neutrophils.Gr-dependent Nr4 a1 upregulation in Kupffer cells may be an important ALF effect regulated by Dex in this process.展开更多
文摘目的:探讨核蛋白样转录因子核受体亚家族2组E成员1(nuclear receptor subfamily 2 group E member 1,NR2E1)对儿童神经母细胞瘤细胞株IMR-32生长、分裂、增殖的影响。方法:应用LipofectamineTM2000将构建的针对核蛋白样转录因子NR2E1的shiRNA质粒载体转染神经母细胞瘤细胞株IMR32,并通过细胞计数法观察细胞生长抑制效应,采用细胞免疫荧光染色检测神经母细胞瘤细胞株IMR32细胞分裂蛋白的表达。结果:核蛋白样转录因子NR2E1的shiRNA质粒转染神经母细胞瘤细胞株IMR32 48 h后,该细胞株生长缓慢;相关细胞核分裂蛋白表达受到明显的抑制。结论:核蛋白样转录因子NR2E1的shiRNA干扰质粒转染神经母细胞瘤细胞株IMR32后,抑制了神经母细胞瘤细胞IMR32的分裂和增殖。
基金the Jin Lei Pediatric Endocrinology Growth Research Fund for Young Physicians(No.PEGRF201607001).
文摘X-linked congenital adrenal hypoplasia is characterised by the acute onset of primary adrenal insufficiency in infancy or early childhood and hypogonadotropic hypogonadism(HH)at puberty,arising from mutations of the nuclear receptor subfamily 0 group B member 1(NR0B1)gene.This study investigated an extended family with two affected males(patient A:23 years and patient B:2 months old)and three carrier females.Sequencing analysis of the NR0B1 gene coding region from the family revealed a novel hemizygous deletion[c.604delT;p.(C202Afs*62)]in the two male patients.Furthermore,the patients'respective mothers and their common grandmother had this heterozygous mutation,but it was not present in the Human Gene Mutation Database.The two male patients showed inconsistent clinical features at onset,particularly in early childhood;however,it is possible that the younger patient will eventually show a delay of puberty,feminisation,and nonspermatogenesis in adulthood,similar to that in the older patient.Identification of a novel NR0BI mutation in this family is important for the diagnosis and genetic counselling of children with primary adrenal insufficiency and HH,and will be helpful for predicting long-term clinical symptoms.
文摘目的探讨核受体亚家族2c成员2(nuclear receptor subfamily 2 group C member 2,NR2C2)在泌乳素瘤的表达水平及其与临床特征的关系。方法采用免疫组化染色和蛋白印迹实验检测46例泌乳素瘤患者的肿瘤组织NR2C2表达水平。用RNA干扰技术敲低MMQ细胞NR2C2表达水平,行细胞增殖实验检测细胞活力,流式细胞仪检测细胞凋亡率。结果按照Knosp分级将患者分为侵袭组和非侵袭组。侵袭组NR2C2表达的免疫组化评分为148.2±42.7,非侵袭组为45.2±28.72;NR2C2表达水平与肿瘤大小成正相关(r=0.327,P=0.039);疏松颗粒型患者的表达水平更高(P=0.003)。蛋白印迹实验检测NR2C2蛋白水平,筛选出Sh-B(23.4%)和Sh-C(34%)片段;干扰24h、48h和72h后,与对照组相比Sh-B组的细胞活力分别下降24.8%、39.2%和48.3%,Sh-C组分别下降19.1%、26.4%和32.5%(均P<0.05)。干扰24h后,Sh-B组AnnexinV阳性细胞为(10.3±3.1)%,PI阳性细胞为(7.3±2.1)%;Sh-C组分别为(8.5±2.3)%和(5.6±1.8)%;均明显高于对照组(均P<0.05)。结论 NR2C2能促进肿瘤生长,与催乳素腺瘤的发生发展密切相关。
文摘核受体在细胞稳态的维持以及疾病的发生发展等方面发挥着重要的作用。为了探究核受体亚家族6A组成员1(nuclear receptor subfamily 6 group A member 1,NR6A1)在肝癌中的作用及机制,首先,分析了癌症基因组图谱(The Cancer Genome Atlas,TCGA)等数据库信息,发现NR6A1在肝癌中异常高表达且与患者预后不良有关;然后,通过CCK-8(Cell Counting Kit-8)、5-乙炔基-2′-脱氧尿苷(5-ethynyl-2′-deoxyuridine,EdU)、划痕实验发现,干扰NR6A1使肝癌细胞的增殖明显受到抑制但不影响细胞的迁移;其次,通过免疫共沉淀、免疫荧光、RNA干扰和过表达等实验,鉴定出N-myc下游调控基因1(N-myc downstream-regulated gene 1,NDRG1)是NR6A1在肝癌中的互作蛋白质,二者在肝癌中的表达呈正相关,且NR6A1正调控NDRG1的表达;最后,利用功能拯救实验证实,干扰NDRG1可以抑制NR6A1过表达造成的肝癌细胞增殖增强的现象。综上可知,NR6A1通过与NDRG1相互结合且上调NDRG1的表达来发挥促癌作用。
文摘目的 探讨乳腺癌患者血清核受体亚家族C组成员2(nuclear receptor subfamily 3, group C, member 2,NR3C2),DNA甲基化转移酶-3A[DNA(cytosine-5)-methyltransferase 3A,DNMT3A]水平及其临床诊断价值。方法收集复旦大学附属华东医院2017年5月~2020年12月期间住院的94例乳腺癌患者为乳腺癌组,另选取同期健康体检者86例作为对照组。酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测两组血清NR3C2和DNMT3A水平,Pearson法分析乳腺癌患者血清NR3C2和DNMT3A表达水平相关性,多因素Logistic回归分析乳腺癌发生的影响因素,受试者工作特征(receiver operating characteristic,ROC)曲线评估NR3C2和DNMT3A对乳腺癌的诊断价值。结果 乳腺癌组患者血清NR3C2水平为317.84±33.47 ng/L,低于对照组(374.25±47.72ng/L),DNMT3A的表达水平为451.63±75.47μg/L,高于对照组(349.85±63.72μg/L),差异有统计学意义(t=9.243,9.729,均P<0.05)。Pearson分析结果显示,乳腺癌患者血清NR3C2与DNMT3A表达水平存在明显负相关(r=-0.501,P=0.000)。Logistic回归分析结果显示,NR3C2高水平为乳腺癌发生的保护因素(OR=0.563,95%CI:0.372~0.851,P=0.006),DNMT3A高水平是乳腺癌发生的危险因素(OR=1.834,95%CI:1.249~2.693,P=0.002)。ROC曲线结果发现,血清NR3C2与DNMT3A诊断乳腺癌的曲线下面积(area under the curve,AUC)分别为0.853(0.791~0.915),0.930(0.896~0.965),当两者联合时其AUC为0.969(0.949~0.990),高于两者单独检测(Z=3.460,1.894,P=0.000,0.034)。结论 乳腺癌患者血清NR3C2表达水平降低,DNMT3A表达水平升高,两者联合检测能够提高乳腺癌的诊断价值。
基金Project supported by the Zhejiang Provincial Natural Science Foundation of China(No.LEZ20H260001)the National Natural Science Foundation of China(No.81700552)。
文摘Background and objective:Acute liver failure(ALF)is a type of disease with high mortality and rapid progression with no specific treatment methods currently available.Glucocorticoids exert beneficial clinical effects on therapy for ALF.However,the mechanism of this effect remains unclear and when to use glucocorticoids in patients with ALF is difficult to determine.The purpose of this study was to investigate the specific immunological mechanism of dexamethasone(Dex)on treatment of ALF induced by lipopolysaccharide(LPS)/D-galactosamine(D-Ga IN)in mice.Methods:Male C57 BL/6 mice were given LPS and D-Ga IN by intraperitoneal injection to establish an animal model of ALF.Dex was administrated to these mice and its therapeutic effect was observed.Hematoxylin and eosin(H&E)staining was used to determine liver pathology.Multicolor flow cytometry,cytometric bead array(CBA)method,and next-generation sequencing were performed to detect changes of messenger RNA(m RNA)in immune cells,cytokines,and Kupffer cells,respectively.Results:A mouse model of ALF can be constructed successfully using LPS/D-Ga IN,which causes a cytokine storm in early disease progression.Innate immune cells change markedly with progression of liver failure.Earlier use of Dex,at 0 h rather than 1 h,could significantly improve the progression of ALF induced by LPS/D-Ga IN in mice.Numbers of innate immune cells,especially Kupffer cells and neutrophils,increased significantly in the Dex-treated group.In vivo experiments indicated that the therapeutic effect of Dex is exerted mainly via the glucocorticoid receptor(Gr).Sequencing of Kupffer cells revealed that Dex could increase m RNA transcription level of nuclear receptor subfamily 4 group A member 1(Nr4 a1),and that this effect disappeared after Gr inhibition.Conclusions:In LPS/D-Ga IN-induced ALF mice,early administration of Dex improved ALF by increasing the numbers of innate immune cells,especially Kupffer cells and neutrophils.Gr-dependent Nr4 a1 upregulation in Kupffer cells may be an important ALF effect regulated by Dex in this process.
